HomeInsightsStock Comparison

Gland Pharma Ltd vs Hindustan Bio Sciences Ltd Stock Comparison

Gland Pharma Ltd vs Hindustan Bio Sciences Ltd Stock Comparison

Last Updated on: Jul 09, 2025

Key Highlights

  • The Latest Trading Price of Gland Pharma Ltd is ₹ 1890 as of 09 Jul 14:06.
  • The P/E Ratio of Gland Pharma Ltd changed from 40.7 on March 2021 to 39.3 on March 2024 . This represents a CAGR of -0.87% over 4 yearsThe P/E Ratio of Hindustan Bio Sciences Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Gland Pharma Ltd changed from ₹ 40535 crore on March 2021 to ₹ 30338 crore on March 2024 . This represents a CAGR of -6.99% over 4 yearsThe Market Cap of Hindustan Bio Sciences Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Gland Pharma Ltd for the Mar '25 is ₹ 1468 crore as compare to the Dec '24 revenue of ₹ 1442 crore. This represent the growth of 1.83% The revenue of Hindustan Bio Sciences Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Gland Pharma Ltd for the Mar '25 is ₹ 391.54 crore as compare to the Dec '24 ebitda of ₹ 418.45 crore. This represent the decline of -6.43% The ebitda of Hindustan Bio Sciences Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Gland Pharma Ltd changed from ₹ 194.1 crore to ₹ 186.54 crore over 8 quarters. This represents a CAGR of -1.97% The net profit of Hindustan Bio Sciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Gland Pharma Ltd changed from 31.57 % on March 2024 to 31.57 % on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Hindustan Bio Sciences Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Gland Pharma Ltd

  • Gland Pharma Limited was incorporated as Gland Pharma Private Limited', a private limited company on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
  • Subsequently, the name of the Company was changed to Gland Pharma Limited' and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
  • The Company is primarily engaged in manufacturing injectable formulations. The company is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019.
  • The company has 8 manufacturing facilities in India, comprising four finished formulations facilities with a total of 23 production lines and three API facilities.

About Hindustan Bio Sciences Ltd

  • Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991.
  • The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors.
  • The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates. Previously, it was engaged in cement manufacturing and due to sluggish in the industry the company diversified its business into Bio Technology & Pharmaceuticals activities and the name of the Company was changed from Garuda Cements to Hindustan Bio-Sciences Ltd. In 2001, it diversified into software field and subsequently changed its name to Hindustan Softel Limited which presently got changed into Hindustan Bio Sciences Ltd.

Gland Pharma Ltd News Hub

News

Gland Pharma Ltd soars 0.08%, gains for fifth straight session

Gland Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs 1781...

Read more

26 Jun 2025 13:00

News

Gland Pharma's JNPC facility completes USFDA inspection

Gland Pharma announced that following the Pre-approval inspection (PAI) for Sterile APIs a...

Read more

24 Jun 2025 11:12

News

Gland Pharma gains after receiving EIR from USFDA for Visakhapatnam facility

As per the exchange filing dated 25 February 2025, the USFDA had conducted a pre-approval ...

Read more

24 Jun 2025 10:58

News

Gland Pharma Ltd gains for third consecutive session

Gland Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 1...

Read more

17 Jun 2025 13:05

News

Gland Pharma Ltd soars 0.15%, gains for fifth straight session

Gland Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs 1650...

Read more

10 Jun 2025 13:00

News

Gland Pharma receives USFDA approval for Angiotensin II Acetate Injection 2.5 mg/mL

Gland Pharma has received approval from the United States Food and Drug Administration (US...

Read more

04 Jun 2025 09:06

Hindustan Bio Sciences Ltd News Hub

News

Hindustan Bio Sciences to announce Quarterly Result

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

20 May 2025 17:21

News

Hindustan Bio Sciences announces board meeting date

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 23 ...

Read more

16 Apr 2025 10:41

News

Hindustan Bio Sciences to conduct board meeting

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

20 Jan 2025 17:29

News

Hindustan Bio Sciences to table results

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

17 Oct 2024 17:15

News

Hindustan Bio Sciences to hold AGM

Hindustan Bio Sciences announced that the 32nd Annual General Meeting (AGM) of the company...

Read more

02 Aug 2024 16:49

News

Hindustan Bio Sciences schedules AGM

Hindustan Bio Sciences announced that the 32th Annual General Meeting (AGM) of the company...

Read more

02 Aug 2024 16:42

SWOT Analysis Of Gland Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Hindustan Bio Sciences Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gland Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Hindustan Bio Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Gland Pharma Ltd and Hindustan Bio Sciences Ltd

Which company has a larger market capitalization, Gland Pharma Ltd or Hindustan Bio Sciences Ltd?

Market cap of Gland Pharma Ltd is 31,099 Cr while Market cap of Hindustan Bio Sciences Ltd is 9 Cr

What are the key factors driving the stock performance of Gland Pharma Ltd and Hindustan Bio Sciences Ltd?

The stock performance of Gland Pharma Ltd and Hindustan Bio Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gland Pharma Ltd and Hindustan Bio Sciences Ltd?

As of July 9, 2025, the Gland Pharma Ltd stock price is INR ₹1887.6. On the other hand, Hindustan Bio Sciences Ltd stock price is INR ₹9.23.

How do dividend payouts of Gland Pharma Ltd and Hindustan Bio Sciences Ltd compare?

To compare the dividend payouts of Gland Pharma Ltd and Hindustan Bio Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions